Cargando…

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response

Detalles Bibliográficos
Autores principales:	Antonios, Joseph, Soto, Horacio, Orpilla, Joey, Shin, Namjo, Everson, Richard, Liau, Linda, Prins, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652564/ http://dx.doi.org/10.1186/2051-1426-3-S2-P393

Ejemplares similares

Plant sterols induce intestinal tumor formation in gender-related manner in ApcMin mice
por: Marttinen, Maija, et al.
Publicado: (2012)

Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015)

The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
por: Lisiero, Dominique N, et al.
Publicado: (2014)

IL-15 is an inflammatory mediator in the tumor microenvironment
por: Anthony, Scott M, et al.
Publicado: (2015)

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
por: Luke, Jason J, et al.
Publicado: (2015)

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
por: Lee, Alexander H., et al.
Publicado: (2021)

Trp53 inactivation in the tumor microenvironment promotes tumor progression by enhancing pro-inflammatory tumor stromal populations
por: Guo, Gang, et al.
Publicado: (2013)

Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
por: Wu, Tc, et al.
Publicado: (2013)

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
por: Pedersen, Sara R, et al.
Publicado: (2015)

Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment
por: Subbiah, Vivek, et al.
Publicado: (2014)

Mutational spectrum of WTX, WT1, CTNNB1, APC and PLCG2 genes in Wilms tumor defined by massive parallel resequencing
por: Barros, Bruna D, et al.
Publicado: (2012)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
por: Kosmides, Alyssa K, et al.
Publicado: (2014)

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
por: Forget, Marie-Andrée, et al.
Publicado: (2013)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Role of VEGF signalling in the regulation of KDR expression in endothelial and tumoral microenvironment
por: Serpa, Jacinta, et al.
Publicado: (2010)

Muci specific IGE to modify myeloid derived cells of the tumor microenvironment
por: Mollick, J, et al.
Publicado: (2013)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

APC is epigenetically down regulated in advance cases of gallbladder cancer
por: Singh, Dinesh Tekcham, et al.
Publicado: (2014)

Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
por: Kwilas, Anna R, et al.
Publicado: (2014)

Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2014)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
por: Broucek, Joseph, et al.
Publicado: (2014)

Beyond the immediate tumor microenvironment: distinct T cell phenotype and function of tumor-adjacent healthy breast tissue associated with regional metastasis in breast cancer
por: Guo, Yi, et al.
Publicado: (2014)

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy
por: Albershardt, Tina C, et al.
Publicado: (2015)

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
por: Kallinteris, Nikoletta L, et al.
Publicado: (2015)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2013)

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013)

Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
por: Wang, Liang-Chuan S, et al.
Publicado: (2015)

Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice
por: Foote, Jeremy, et al.
Publicado: (2015)

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
por: Zappasodi, Roberta, et al.
Publicado: (2014)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2014)

Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
por: Zha, Yuanyuan, et al.
Publicado: (2015)

Aggressive gastric cancer in a patient with an APC mutation and a monoallelic MYH mutation
por: Wise, Paul, et al.
Publicado: (2010)

The APC–tumor connection
por: LeBrasseur, Nicole
Publicado: (2003)

Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2014)

Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment
por: Li, Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h9s84cvvnduo2adcgd3o6go0lo